Antisense oligonucleotides for treating allergy and...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 48/00 (2006.01) A61K 31/115 (2006.01) A61K 31/711 (2006.01)

Patent

CA 2584457

Antisense oligonucleotides for treating and/or preventing at least one of asthma, allergy, hypereosinophilia, general inflammation and cancer are provided. The oligonucleotides are directed against nucleic acid sequences coding for a receptor selected from the group consisting of a CCR3 receptor and a common sub-unit of IL-3, IL-5 and GM-CSF receptors.

Oligonucléotides antisens pour le traitement et/ou la prévention d'au moins une des pathologies suivantes: l'asthme, l'allergie, l'hyperéosinophilie, l'inflammation générale et le cancer. Les oligonucléotides sont dirigés contre les séquences d'acide nucléique codant un récepteur sélectionné dans le groupe constitué d'un récepteur CCR3 et d'une sous-unité commune de récepteurs IL-3, IL-5 et GM-CSF.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Antisense oligonucleotides for treating allergy and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antisense oligonucleotides for treating allergy and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antisense oligonucleotides for treating allergy and... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1429378

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.